Found: 708
Select item for more details and to access through your institution.
Hydroxyurea maintains working memory function in pediatric sickle cell disease.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0296196
- By:
- Publication type:
- Article
Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304644
- By:
- Publication type:
- Article
Effect of Hydroxyurea on Morphology, Proliferation, and Protein Expression on Taenia crassiceps WFU Strain.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6061, doi. 10.3390/ijms25116061
- By:
- Publication type:
- Article
Initial Low-Dose Hydroxyurea and Anagrelide Combination in Essential Thrombocythemia: Comparable Response with Lower Toxicity.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 10, p. 2901, doi. 10.3390/jcm13102901
- By:
- Publication type:
- Article
Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Sickle Cell Disease in an Older Adult Population: A Retrospective Review of Health Care Resource Utilization.
- Published in:
- Population Health Management, 2024, v. 27, n. 2, p. 120, doi. 10.1089/pop.2023.0268
- By:
- Publication type:
- Article
Prevalence of Stroke in Individuals with Sickle Cell Disease Pre- and during Hydroxyurea Uses: A Descriptive Cross-Sectional Study in Tanzania.
- Published in:
- Advances in Hematology, 2024, v. 2024, p. 1, doi. 10.1155/2024/7950925
- By:
- Publication type:
- Article
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 379, doi. 10.1111/ejh.14124
- By:
- Publication type:
- Article
Hydroxyurea at escalated dose versus fixed low‐dose hydroxyurea in adults with sickle cell disease.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 466, doi. 10.1111/ejh.14138
- By:
- Publication type:
- Article
Role of cell proliferation in strobilation of moon jellyfish Aurelia coerulea.
- Published in:
- Fisheries Science, 2024, v. 90, n. 2, p. 179, doi. 10.1007/s12562-023-01744-z
- By:
- Publication type:
- Article
The negative impact of medications on wound healing.
- Published in:
- Wound Practice & Research, 2024, v. 32, n. 1, p. 17, doi. 10.33235/wpr.32.1.17-24
- By:
- Publication type:
- Article
Male Fertility and Fatherhood in Chronic Myeloid Leukemia: Current Understanding and Future Perspectives.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 791, doi. 10.3390/cancers16040791
- By:
- Publication type:
- Article
Impact of splenectomy on circulating microparticles in patients with sickle cell anemia.
- Published in:
- International Journal of Laboratory Hematology, 2024, v. 46, n. 1, p. 141, doi. 10.1111/ijlh.14162
- By:
- Publication type:
- Article
HIF2-α Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response (MMR) versus in Those Not Achieving MMR.
- Published in:
- Journal of Blood Medicine, 2024, v. 15, p. 61, doi. 10.2147/JBM.S436015
- By:
- Publication type:
- Article
CLINICAL OUTCOMES OF HYDROXYUREA THERAPY IN THE MANAGEMENT OF SICKLE CELL DISEASE IN A TERTIARY HEALTH FACILITY IN SOUTHERN NIGERIA.
- Published in:
- Journal of Pharmaceutical & Allied Sciences, 2024, v. 21, n. 1, p. 4071
- By:
- Publication type:
- Article
Adherence to Hydroxyurea and Patients' Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 1, p. 124, doi. 10.3390/medicina60010124
- By:
- Publication type:
- Article
Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.
- Published in:
- Turkish Journal of Hematology, 2024, v. 41, n. 1, p. 26, doi. 10.4274/tjh.galenos.2024.2023.0430
- By:
- Publication type:
- Article
Severe hypoglycemia caused by hydroxyurea interference on continuous glucose sensor integrated with advanced hybrid closed-loop system: a case report.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 12, p. 1749, doi. 10.1007/s00592-023-02166-0
- By:
- Publication type:
- Article
Hyperleukocytosis in Acute Myeloid Leukemia: Considerations for Inpatient Diagnosis and Management.
- Published in:
- Clinical Journal of Oncology Nursing, 2023, v. 27, n. 6, p. 589, doi. 10.1188/23.CJON.589-593
- By:
- Publication type:
- Article
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1603, doi. 10.1007/s40273-023-01294-3
- By:
- Publication type:
- Article
Use of Disease-Modifying Treatments in Patients With Sickle Cell Disease.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2344546, doi. 10.1001/jamanetworkopen.2023.44546
- By:
- Publication type:
- Article
Hydroxyurea and inactivation of checkpoint kinase MEC1 inhibit transcription termination and pre-mRNA cleavage at polyadenylation sites in budding yeast.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40294-3
- By:
- Publication type:
- Article
Current therapies for classic myeloproliferative neoplasms: A focus on pathophysiology and supportive care.
- Published in:
- American Journal of Health-System Pharmacy, 2023, v. 80, n. 22, p. 1624, doi. 10.1093/ajhp/zxad181
- By:
- Publication type:
- Article
Effect of hydroxyurea on SP1, LIN28B, IGF2BP3, COL4A5, BCL2, gamma globin genes expression: an in vitro study.
- Published in:
- Egyptian Journal of Medical Human Genetics, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s43042-023-00452-8
- By:
- Publication type:
- Article
Genome instability footprint under rapamycin and hydroxyurea treatments.
- Published in:
- PLoS Genetics, 2023, v. 19, n. 11, p. 1, doi. 10.1371/journal.pgen.1011012
- By:
- Publication type:
- Article
Two independent DNA repair pathways cause mutagenesis in template switching deficient Saccharomyces cerevisiae.
- Published in:
- Genetics, 2023, v. 225, n. 3, p. 1, doi. 10.1093/genetics/iyad153
- By:
- Publication type:
- Article
Hydroxyurée : pourquoi et comment l'utiliser chez l'enfant atteint de drépanocytose ?
- Published in:
- Hematologie, 2023, v. 29, n. 6, p. 354, doi. 10.1684/hma.2023.1826
- By:
- Publication type:
- Article
Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child.
- Published in:
- Laboratory Medicine, 2023, v. 54, n. 6, p. e170, doi. 10.1093/labmed/lmad053
- By:
- Publication type:
- Article
Hydroxyurea does not reverse functional alterations of the nitric oxide-cGMP pathway associated with priapism phenotype in corpus cavernosum from sickle cell mouse.
- Published in:
- PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0292706
- By:
- Publication type:
- Article
A Normalization Protocol Reduces Edge Effect in High-Throughput Analyses of Hydroxyurea Hypersensitivity in Fission Yeast.
- Published in:
- Biomedicines, 2023, v. 11, n. 10, p. 2829, doi. 10.3390/biomedicines11102829
- By:
- Publication type:
- Article
Nails blue? Don't be sad, the cause may be discoverable.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 10, p. 344, doi. 10.1007/s40267-023-01022-z
- By:
- Publication type:
- Article
Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
- Published in:
- Dubai Medical Journal, 2023, v. 6, n. 4, p. 301, doi. 10.1159/000531257
- By:
- Publication type:
- Article
Change in Polycythemia Vera Treatment: Ropeginterferon Alfa-2b in Light of Current Trials.
- Published in:
- Turkish Journal of Hematology, 2023, v. 40, n. 4, p. 266, doi. 10.4274/tjh.galenos.2023.2023.0419
- By:
- Publication type:
- Article
Real-World Clinical Characterisation of Polycythaemia Vera Patients from a Prospective Registry in Portugal: Is Resistance to Hydroxyurea a Reality?
- Published in:
- Hematology Reports, 2023, v. 15, n. 3, p. 532, doi. 10.3390/hematolrep15030056
- By:
- Publication type:
- Article
Hydroxyurea-associated multiple squamous cell carcinoma developed on the dermatomyositis-like eruption.
- Published in:
- Indian Journal of Dermatology, 2023, v. 68, n. 5, p. 588, doi. 10.4103/ijd.ijd_242_23
- By:
- Publication type:
- Article
Hydroxyurea and inactivation of checkpoint kinase MEC1 inhibit transcription termination and pre-mRNA cleavage at polyadenylation sites in budding yeast.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40294-3
- By:
- Publication type:
- Article
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3706, doi. 10.3390/cancers15143706
- By:
- Publication type:
- Article
Factors associated with health-related quality of life in children with sickle cell disease.
- Published in:
- Nursing Children & Young People, 2023, v. 35, n. 4, p. 22, doi. 10.7748/ncyp.2023.e1448
- By:
- Publication type:
- Article
Identifying Patients with Polycythemia Vera at Risk of Thrombosis after Hydroxyurea Initiation: The Polycythemia Vera—Advanced Integrated Models (PV-AIM) Project.
- Published in:
- Biomedicines, 2023, v. 11, n. 7, p. 1925, doi. 10.3390/biomedicines11071925
- By:
- Publication type:
- Article
Estimated Level of Plasma Micro RNA-210 in Beta Thalassemia Patients and Its Relation to Hemoglobin F Level and Disease Severity.
- Published in:
- Journal of Applied Hematology, 2023, v. 14, n. 3, p. 208, doi. 10.4103/joah.joah_42_23
- By:
- Publication type:
- Article
Leveraging mathematical modeling to analyze nonadherence for hydroxyurea therapy in sickle cell disease.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 6, p. 748, doi. 10.1002/psp4.12945
- By:
- Publication type:
- Article
Chronic neutrophilic leukemia associated with thrombocytosis and a CSF3R Q781* nonsense mutation.
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 3, p. e79, doi. 10.1111/ijlh.14015
- By:
- Publication type:
- Article
Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 857, doi. 10.3390/ph16060857
- By:
- Publication type:
- Article
Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?—A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 8792, doi. 10.3390/ijms24108792
- By:
- Publication type:
- Article
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 5, p. 419, doi. 10.1002/phar.2793
- By:
- Publication type:
- Article
Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challenges.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 5, p. 430, doi. 10.1002/phar.2792
- By:
- Publication type:
- Article
Hydroxyurea and pyridostigmine repurposed for treating Covid-19 multi-systems dysfunctions.
- Published in:
- AIMS Medical Science, 2023, v. 10, n. 2, p. 118, doi. 10.3934/medsci.2023010
- By:
- Publication type:
- Article
Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high‐risk essential thrombocythemia.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8073, doi. 10.1002/cam4.5602
- By:
- Publication type:
- Article
골수증식종양의 치료제인 하이드록시유레아의 부작용.
- Published in:
- Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2023, v. 66, n. 4, p. 253, doi. 10.5124/jkma.2023.66.4.253
- By:
- Publication type:
- Article
Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 3, p. e234584, doi. 10.1001/jamanetworkopen.2023.4584
- By:
- Publication type:
- Article